Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells

Eun Joon Lee, Prakash Rath, Jimei Liu, Dungsung Ryu, Lirong Pei, Satish K. Noonepalle, Austin Y. Shull, Qi Feng, N. Scott Litofsky, Douglas C. Miller, Douglas C. Anthony, Mark D. Kirk, John Laterra, Libin Deng, Hong Bo Xin, Xinguo Wang, Jeong Hyeon Choi, Huidong Shi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Glioblastoma (GBM) is the most common and most aggressive primary brain tumor in adults. The existence of a small population of stem-like tumor cells that efficiently propagate tumors and resist cytotoxic therapy is one proposed mechanism leading to the resilient behavior of tumor cells and poor prognosis. In this study, we performed an in-depth analysis of the DNA methylation landscape in GBM-derived cancer stem cells (GSCs). Parallel comparisons of primary tumors and GSC lines derived from these tumors with normal controls (a neural stem cell (NSC) line and normal brain tissue) identified groups of hyper- and hypomethylated genes that display a trend of either increasing or decreasing methylation levels in the order of controls, primary GBMs, and their counterpart GSC lines, respectively. Interestingly, concurrent promoter hypermethylation and gene body hypomethylation were observed in a subset of genes including MGMT, AJAP1 and PTPRN2. These unique DNA methylation signatures were also found in primary GBM-derived xenograft tumors indicating that they are not tissue culture-related epigenetic changes. Integration of GSC-specific epigenetic signatures with gene expression analysis further identified candidate tumor suppressor genes that are frequently down-regulated in GBMs such as SPINT2, NEFM and PENK. Forced re-expression of SPINT2 reduced glioma cell proliferative capacity, anchorage independent growth, cell motility, and tumor sphere formation invitro. The results from this study demonstrate that GSCs possess unique epigenetic signatures that may play important roles in the pathogenesis of GBM.

Original languageEnglish (US)
Pages (from-to)355-371
Number of pages17
JournalJournal of Genetics and Genomics
Volume42
Issue number7
DOIs
StatePublished - Jul 20 2015

Fingerprint

Neoplastic Stem Cells
DNA Methylation
Glioblastoma
Epigenomics
Neoplasms
Cell Line
Genes
Neural Stem Cells
Tumor Suppressor Genes
Transcriptome
Heterografts
Brain Neoplasms
Glioma
Methylation
Cell Movement
Brain
Growth
Population

Keywords

  • Cancer stem cells
  • DNA methylation
  • Glioblastoma
  • SPINT2

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells. / Lee, Eun Joon; Rath, Prakash; Liu, Jimei; Ryu, Dungsung; Pei, Lirong; Noonepalle, Satish K.; Shull, Austin Y.; Feng, Qi; Litofsky, N. Scott; Miller, Douglas C.; Anthony, Douglas C.; Kirk, Mark D.; Laterra, John; Deng, Libin; Xin, Hong Bo; Wang, Xinguo; Choi, Jeong Hyeon; Shi, Huidong.

In: Journal of Genetics and Genomics, Vol. 42, No. 7, 20.07.2015, p. 355-371.

Research output: Contribution to journalArticle

Lee, EJ, Rath, P, Liu, J, Ryu, D, Pei, L, Noonepalle, SK, Shull, AY, Feng, Q, Litofsky, NS, Miller, DC, Anthony, DC, Kirk, MD, Laterra, J, Deng, L, Xin, HB, Wang, X, Choi, JH & Shi, H 2015, 'Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells', Journal of Genetics and Genomics, vol. 42, no. 7, pp. 355-371. https://doi.org/10.1016/j.jgg.2015.06.003
Lee, Eun Joon ; Rath, Prakash ; Liu, Jimei ; Ryu, Dungsung ; Pei, Lirong ; Noonepalle, Satish K. ; Shull, Austin Y. ; Feng, Qi ; Litofsky, N. Scott ; Miller, Douglas C. ; Anthony, Douglas C. ; Kirk, Mark D. ; Laterra, John ; Deng, Libin ; Xin, Hong Bo ; Wang, Xinguo ; Choi, Jeong Hyeon ; Shi, Huidong. / Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells. In: Journal of Genetics and Genomics. 2015 ; Vol. 42, No. 7. pp. 355-371.
@article{b3a05efa66eb470aa24606628c57bf26,
title = "Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells",
abstract = "Glioblastoma (GBM) is the most common and most aggressive primary brain tumor in adults. The existence of a small population of stem-like tumor cells that efficiently propagate tumors and resist cytotoxic therapy is one proposed mechanism leading to the resilient behavior of tumor cells and poor prognosis. In this study, we performed an in-depth analysis of the DNA methylation landscape in GBM-derived cancer stem cells (GSCs). Parallel comparisons of primary tumors and GSC lines derived from these tumors with normal controls (a neural stem cell (NSC) line and normal brain tissue) identified groups of hyper- and hypomethylated genes that display a trend of either increasing or decreasing methylation levels in the order of controls, primary GBMs, and their counterpart GSC lines, respectively. Interestingly, concurrent promoter hypermethylation and gene body hypomethylation were observed in a subset of genes including MGMT, AJAP1 and PTPRN2. These unique DNA methylation signatures were also found in primary GBM-derived xenograft tumors indicating that they are not tissue culture-related epigenetic changes. Integration of GSC-specific epigenetic signatures with gene expression analysis further identified candidate tumor suppressor genes that are frequently down-regulated in GBMs such as SPINT2, NEFM and PENK. Forced re-expression of SPINT2 reduced glioma cell proliferative capacity, anchorage independent growth, cell motility, and tumor sphere formation invitro. The results from this study demonstrate that GSCs possess unique epigenetic signatures that may play important roles in the pathogenesis of GBM.",
keywords = "Cancer stem cells, DNA methylation, Glioblastoma, SPINT2",
author = "Lee, {Eun Joon} and Prakash Rath and Jimei Liu and Dungsung Ryu and Lirong Pei and Noonepalle, {Satish K.} and Shull, {Austin Y.} and Qi Feng and Litofsky, {N. Scott} and Miller, {Douglas C.} and Anthony, {Douglas C.} and Kirk, {Mark D.} and John Laterra and Libin Deng and Xin, {Hong Bo} and Xinguo Wang and Choi, {Jeong Hyeon} and Huidong Shi",
year = "2015",
month = "7",
day = "20",
doi = "10.1016/j.jgg.2015.06.003",
language = "English (US)",
volume = "42",
pages = "355--371",
journal = "Journal of Genetics and Genomics",
issn = "1673-8527",
publisher = "Institute of Genetics and Developmental Biology",
number = "7",

}

TY - JOUR

T1 - Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells

AU - Lee, Eun Joon

AU - Rath, Prakash

AU - Liu, Jimei

AU - Ryu, Dungsung

AU - Pei, Lirong

AU - Noonepalle, Satish K.

AU - Shull, Austin Y.

AU - Feng, Qi

AU - Litofsky, N. Scott

AU - Miller, Douglas C.

AU - Anthony, Douglas C.

AU - Kirk, Mark D.

AU - Laterra, John

AU - Deng, Libin

AU - Xin, Hong Bo

AU - Wang, Xinguo

AU - Choi, Jeong Hyeon

AU - Shi, Huidong

PY - 2015/7/20

Y1 - 2015/7/20

N2 - Glioblastoma (GBM) is the most common and most aggressive primary brain tumor in adults. The existence of a small population of stem-like tumor cells that efficiently propagate tumors and resist cytotoxic therapy is one proposed mechanism leading to the resilient behavior of tumor cells and poor prognosis. In this study, we performed an in-depth analysis of the DNA methylation landscape in GBM-derived cancer stem cells (GSCs). Parallel comparisons of primary tumors and GSC lines derived from these tumors with normal controls (a neural stem cell (NSC) line and normal brain tissue) identified groups of hyper- and hypomethylated genes that display a trend of either increasing or decreasing methylation levels in the order of controls, primary GBMs, and their counterpart GSC lines, respectively. Interestingly, concurrent promoter hypermethylation and gene body hypomethylation were observed in a subset of genes including MGMT, AJAP1 and PTPRN2. These unique DNA methylation signatures were also found in primary GBM-derived xenograft tumors indicating that they are not tissue culture-related epigenetic changes. Integration of GSC-specific epigenetic signatures with gene expression analysis further identified candidate tumor suppressor genes that are frequently down-regulated in GBMs such as SPINT2, NEFM and PENK. Forced re-expression of SPINT2 reduced glioma cell proliferative capacity, anchorage independent growth, cell motility, and tumor sphere formation invitro. The results from this study demonstrate that GSCs possess unique epigenetic signatures that may play important roles in the pathogenesis of GBM.

AB - Glioblastoma (GBM) is the most common and most aggressive primary brain tumor in adults. The existence of a small population of stem-like tumor cells that efficiently propagate tumors and resist cytotoxic therapy is one proposed mechanism leading to the resilient behavior of tumor cells and poor prognosis. In this study, we performed an in-depth analysis of the DNA methylation landscape in GBM-derived cancer stem cells (GSCs). Parallel comparisons of primary tumors and GSC lines derived from these tumors with normal controls (a neural stem cell (NSC) line and normal brain tissue) identified groups of hyper- and hypomethylated genes that display a trend of either increasing or decreasing methylation levels in the order of controls, primary GBMs, and their counterpart GSC lines, respectively. Interestingly, concurrent promoter hypermethylation and gene body hypomethylation were observed in a subset of genes including MGMT, AJAP1 and PTPRN2. These unique DNA methylation signatures were also found in primary GBM-derived xenograft tumors indicating that they are not tissue culture-related epigenetic changes. Integration of GSC-specific epigenetic signatures with gene expression analysis further identified candidate tumor suppressor genes that are frequently down-regulated in GBMs such as SPINT2, NEFM and PENK. Forced re-expression of SPINT2 reduced glioma cell proliferative capacity, anchorage independent growth, cell motility, and tumor sphere formation invitro. The results from this study demonstrate that GSCs possess unique epigenetic signatures that may play important roles in the pathogenesis of GBM.

KW - Cancer stem cells

KW - DNA methylation

KW - Glioblastoma

KW - SPINT2

UR - http://www.scopus.com/inward/record.url?scp=84938237537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938237537&partnerID=8YFLogxK

U2 - 10.1016/j.jgg.2015.06.003

DO - 10.1016/j.jgg.2015.06.003

M3 - Article

C2 - 26233891

AN - SCOPUS:84938237537

VL - 42

SP - 355

EP - 371

JO - Journal of Genetics and Genomics

JF - Journal of Genetics and Genomics

SN - 1673-8527

IS - 7

ER -